Datasets:
Licence question before use - scope of the USD 250 machine-learning fee
Dear dataset maintainers,
We are a medical AI company based in Singapore (ANCHORAGENT TECHNOLOGIES PTE. LTD.).
We have been granted access to the OmniAbnorm-CT-14K repository, but we have not
downloaded or used the dataset, and we have not yet paid the Radiopaedia
machine-learning fee. We would like to establish the correct position before we do
either.
The dataset terms state that a fee of USD 250 per user must be paid through
Radiopaedia's official application system before the dataset is used for
machine-learning projects. We should be grateful for clarification on five points.
Scope of the fee
Does the USD 250 fee authorise commercial use, or is it limited to academic,
research and educational use only?Commercial product development
If the dataset is used to develop or evaluate a commercial medical software
product (not merely for academic publication), is the same USD 250 fee sufficient,
or is a separate commercial licence required? If separate, what are the terms and
the cost?Unit of charge
Is the fee charged per individual user, per organisation, or per project? If
several researchers in one company work with the data, does each need a licence?Derivative works
Does the licence extend to models trained or fine-tuned on the dataset, and to the
commercial deployment of such models? Are there any restrictions on distributing
derived model weights?Application process
What is the application procedure, what information is required, and what is the
typical turnaround time?
For context, our intended use is the development and internal evaluation of a
clinical decision-support system, specifically to assess how well it localises and
describes abnormalities in CT volumes. We do not seek to redistribute the dataset.
If this enquiry should instead be directed to Radiopaedia directly, we would be
grateful for the correct contact address.
Thank you.
Wang Yezhao
Director, ANCHORAGENT TECHNOLOGIES PTE. LTD. (Singapore)